Psy22 - A Review on Epidemiology, Risk Factors and Treatment Patterns in Moderate and Severe Painful Diabetic Neuropathy and Post-Herpetic Neuralgia

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.2599
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Prm65 - Different Cost Effectiveness Models Used for Economic Evaluation in Moderate to Severe Painful Diabetic Neuropathy or Post-Herpetic Neuralgia

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Sensory Phenotype and Risk Factors for Painful Diabetic Neuropathy

Pain
NeurologyAnesthesiologyPain MedicinePharmacology
2017English

Treatment of Shingles and Post-Herpetic Neuralgia

BMJ
1989English

The Pathogenesis and Management of Painful Diabetic Neuropathy: A Review

Diabetic Medicine
Internal MedicineEndocrinologyMetabolismDiabetes
2003English

Painful Diabetic Neuropathy

International Review of Neurobiology
Molecular NeuroscienceNeurologyCellular
2016English

Vascular Risk Factors and Diabetic Neuropathy

Journal of Vascular Surgery
SurgeryCardiovascular MedicineCardiology
2005English

Gabapentin Versus Tricyclic Antidepressants for Diabetic Neuropathy and Post-Herpetic Neuralgia: Discrepancies Between Direct and Indirect Meta-Analyses of Randomized Controlled Trials

Journal of General Internal Medicine
Internal Medicine
2009English

Clinical and Psychosocial Correlates of Post-Herpetic Neuralgia

Journal of Medical Virology
VirologyInfectious Diseases
2008English

Successful Treatment of Post Herpetic Neuralgia and Herpes Zoster (Shingles) With Homeopathic Medicines

Journal of Clinical and Investigative Dermatology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy